| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/11/2009 | EP2021335A1 Heterocyclic compounds as inhibitors of c-fms kinase |
| 02/11/2009 | EP2021035A2 Cell-matrix microspheres, methods for preparation and applications |
| 02/11/2009 | EP2021003A2 Imidazoazephinone compounds |
| 02/11/2009 | EP2020998A1 Compositions and methods for the inhibition of endothelial nitric oxide synthase activity |
| 02/11/2009 | EP1572679B1 Crfr1 selective ligands |
| 02/11/2009 | EP1478236B1 Targeted retrograde gene delivery to motor neurons |
| 02/11/2009 | EP1370561B1 Tetrahydro-pyrazino[1,2-a]indoles for the treatment of central nervous disorders |
| 02/11/2009 | EP1317258B1 Use of allopurinol for the treatment of hypertension |
| 02/11/2009 | EP1228063B1 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 02/11/2009 | EP1210453B1 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 02/11/2009 | CN101365478A Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| 02/11/2009 | CN101365476A Combined use of dpp iv inhibitors and gastrin compounds |
| 02/11/2009 | CN101365452A Methods and compositions for the treatment of vascular disease |
| 02/11/2009 | CN101365446A Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 02/11/2009 | CN101365438A Composition for prevention of recurrence of stroke |
| 02/11/2009 | CN101362803A Fusion proteins of tick anticoagulant peptide and staphylococcus aureus superantigen-like protein, preparation and application thereof |
| 02/11/2009 | CN101362791A Steroidal alkaloid veratramine, preparation method thereof and antihypertensive application |
| 02/11/2009 | CN101362766A Extraction method for preparing high-purity allocryptopine |
| 02/11/2009 | CN101362765A 5,7-diaminopyrazolo '4,3-d!pyrimidines with PDE-5 inhibiting activity |
| 02/11/2009 | CN101362764A 5,7-diaminopyrazolo '4,3-d!pyrimidines with PDE-5 inhibiting activity |
| 02/11/2009 | CN101362749A Sertindole synthesis method |
| 02/11/2009 | CN101362748A Method for preparing sertindole |
| 02/11/2009 | CN101362738A Method for preparing cinepazide maleate |
| 02/11/2009 | CN101362731A Heterocyclic compounds and methods of use |
| 02/11/2009 | CN101362729A Valsartan postprocessing method |
| 02/11/2009 | CN101362728A Valsartan synthesis method |
| 02/11/2009 | CN101362725A Method for preparing tetramethylpyrazine guanidine derivatives and application thereof |
| 02/11/2009 | CN101362724A Tetramethylpyrazine acidamides derivates, preparation method and medicament composition and application |
| 02/11/2009 | CN101361967A Y2/Y4 selective receptor agonists for therapeutic interventions |
| 02/11/2009 | CN101361966A Use of decorin in preparing medicine for treating ischemic cerebrovascular disease |
| 02/11/2009 | CN101361961A Use of polypeptides micro-molecule in preparing medicine for preventing and treating ischemic cerebrovascular disease |
| 02/11/2009 | CN101361945A Traditional Chinese medicine preparation for treating cardio-cerebrovascular disease |
| 02/11/2009 | CN101361920A Traditional Chinese medicine combination of hypotension tranquilization pillow inner |
| 02/11/2009 | CN101361908A Medicine for treating angina |
| 02/11/2009 | CN101361907A Hypoglycemic, antihypertensive formulation and preparation technique thereof |
| 02/11/2009 | CN101361902A Traditional Chinese medicine granules for treating coronary heart disease |
| 02/11/2009 | CN101361884A Traditional Chinese medicine formulation for treating hemorrhoid and preparation method thereof |
| 02/11/2009 | CN101361855A Medicine for reducing and stabilizing blood-pressure |
| 02/11/2009 | CN101361841A Use of traditional Chinese medicine in preparing medicine for treating diabetes cardiomyopathy |
| 02/11/2009 | CN101361831A New use of cape jasmine |
| 02/11/2009 | CN101361827A Functional medicated pillow with microelement capable of perfuming and strengthening the body and prolonging the life |
| 02/11/2009 | CN101361826A Plant extract with angiotensin converting enzyme inhibitor function and use thereof |
| 02/11/2009 | CN101361801A Qiancao Naomaitong medicine for treating apoplexy or the like and preparation method thereof |
| 02/11/2009 | CN101361798A Topical application traditional Chinese medicine for treating apoplexia and flaccid paralysis |
| 02/11/2009 | CN101361797A Traditional Chinese medicine pressure-reduction insoles |
| 02/11/2009 | CN101361795A Medicine composition for treating cerebrovascular disease and quality control method thereof |
| 02/11/2009 | CN101361787A Traditional Chinese medicine formulation for treating hemiparalysis and preparation method thereof |
| 02/11/2009 | CN101361781A Fingerprint checking method of gadol injection |
| 02/11/2009 | CN101361758A Oral liquid special for treating hemorrhoid |
| 02/11/2009 | CN101361750A Use of naringin in preparing antiatherosclerotic medicine |
| 02/11/2009 | CN101361745A Use of SIP in preparing medicine for preventing mesenchymal stem cells apoptosis |
| 02/11/2009 | CN101361740A Pharmacy use of 2,5- bis (hydroxymethyl)-3,6-dimethyl pyrazine and derivates thereof |
| 02/11/2009 | CN101361736A Compound of losartan or pharmaceutical salt thereof and calcium channel blockers or pharmaceutical salt thereof |
| 02/11/2009 | CN101361728A Salvianolic acid A injection and preparation method thereof |
| 02/11/2009 | CN101361726A Use of astaxanthin in preparing medicine capable of preventing and treating cerebral apoplexy |
| 02/11/2009 | CN101361721A Polydatin dispersible tablets and preparation method and use thereof |
| 02/11/2009 | CN101361720A Nebivolol hydrochloric acid orally disintegrating tablet and preparation method thereof |
| 02/11/2009 | CN101361719A Bromhexine hydrochloric acid orally disintegrating tablet production method |
| 02/11/2009 | CN101361717A Batroxobin freeze-dry powder injection and preparation method thereof |
| 02/11/2009 | CN100460017C Total arasaponin precursor liposome and prepn process thereof |
| 02/11/2009 | CN100459992C Blood pressure lowering health tea |
| 02/11/2009 | CN100459990C Medicine for treating coronary heart disease and preparation method thereof |
| 02/11/2009 | CN100459980C 7-Hydroxyepiandrosterone having neuroprotective activity |
| 02/10/2009 | US7488829 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 02/10/2009 | US7488826 Substituted pyrroline kinase inhibitors |
| 02/10/2009 | US7488750 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 02/10/2009 | US7488739 platelet aggregation inhibitors; anti-platelet agent with a high safety profile with a smaller adverse bleeding effect; P2Y12 inhibitor; (2S)-2-({[7-(cyclohexylamino)-1-cyclopentyl-6-fluoro-4-oxo-1,4-dihydroquinolin-3-yl]carbonyl}amino)butanedioic acid |
| 02/10/2009 | US7488738 Such as 4-({4-[[(4-Amino-2,3,5,6-tetramethylanilino)acetyl]-(methyl)amino]-1-piperidino}methyl)benzamide which has neuroprotective effects by inducing calcium binding proteins |
| 02/10/2009 | US7488494 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 02/10/2009 | CA2562418C Sustained release formulation for oral administration of hmg-coa reductase inhibitor and method for the preparation thereof |
| 02/10/2009 | CA2389709C Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 02/10/2009 | CA2386690C Pharmaceutical tramadol salts |
| 02/10/2009 | CA2328396C New substituted amides, their production and their use |
| 02/10/2009 | CA2294098C Novel thyroid receptor ligands and method |
| 02/10/2009 | CA2286671C Method and formulation for treating vascular disease |
| 02/10/2009 | CA2211270C Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 02/10/2009 | CA2208671C Substituted imides as tnf inhibitors |
| 02/05/2009 | WO2009017777A2 Metabolites and derivatives of ambrisentan |
| 02/05/2009 | WO2009017236A1 Pyridopyrimidin-4-one derivatives |
| 02/05/2009 | WO2009017190A1 Fused bicyclic compound |
| 02/05/2009 | WO2009017161A1 Inhibitory agent for inflammatory cytokine |
| 02/05/2009 | WO2009016088A1 The use of benzamide derivatives for the treatment of cns disorders |
| 02/05/2009 | WO2009015812A2 Prodrugs of 2-amino-6- ( { [2- (4-chlorphenyl) -1, 3-thiaz0l-4-yl] methyl}thio) -4- [4- ( 2 -hydroxyethoxy) phenyl] pyridin-3, 5-dicarbonitrile |
| 02/05/2009 | WO2009015811A1 Dipeptoid prodrugs and the use thereof |
| 02/05/2009 | WO2009015776A1 Substituted aryloxazoles and the use thereof |
| 02/05/2009 | WO2009015766A1 Single-phase pharmaceutical composite preparation (dienogest and ethinyl estradiol) for oral therapy for regulation of blood pressure |
| 02/05/2009 | WO2009015561A1 The use of leonurine and compositions thereof |
| 02/05/2009 | WO2009015547A1 A medicinal composition for the treatment of angiocadiopathy and hyperlipemia |
| 02/05/2009 | WO2008137787A3 Combination therapy with a compound acting as a platelet adp receptor inhibitor |
| 02/05/2009 | WO2008116912A3 Purinyl derivatives and their use as potassium channel modulators |
| 02/05/2009 | WO2008016640A3 Use of poloxamer for the prevention and/or treatment of heart failure |
| 02/05/2009 | WO2003099808A8 Substituted heterocyclic compounds and methods of use |
| 02/05/2009 | US20090036761 Noninvasive measurement of chemical substances |
| 02/05/2009 | US20090036675 New process for production of oxabispidines |
| 02/05/2009 | US20090036540 Guanylhydrazones in Methods of Treatment or Diagnosis as Modulators of Signal Transduction |
| 02/05/2009 | US20090036527 Therapeutic Application Of Leonurine In Treating Cardiomyopathy |
| 02/05/2009 | US20090036524 Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of nf-kappab |
| 02/05/2009 | US20090036520 Combinations of vasoprotective agents and formulations containing them |
| 02/05/2009 | US20090036519 Peroxisome proliferator activated receptor ligand and process for producing the same |
| 02/05/2009 | US20090036517 Anti-angiogenic compositions and methods of use |